JP2010532665A - 細菌性および真菌性敗血症の病原菌の高感度な増幅および検出用の核酸配列およびその組合せ - Google Patents
細菌性および真菌性敗血症の病原菌の高感度な増幅および検出用の核酸配列およびその組合せ Download PDFInfo
- Publication number
- JP2010532665A JP2010532665A JP2010515331A JP2010515331A JP2010532665A JP 2010532665 A JP2010532665 A JP 2010532665A JP 2010515331 A JP2010515331 A JP 2010515331A JP 2010515331 A JP2010515331 A JP 2010515331A JP 2010532665 A JP2010532665 A JP 2010532665A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- deletions
- nucleic acid
- oligonucleotide
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical group 0.000 title claims abstract description 278
- 244000052769 pathogen Species 0.000 title claims abstract description 76
- 238000003199 nucleic acid amplification method Methods 0.000 title claims description 159
- 230000003321 amplification Effects 0.000 title claims description 153
- 238000001514 detection method Methods 0.000 title claims description 81
- 230000001580 bacterial effect Effects 0.000 title abstract description 29
- 206010058872 Fungal sepsis Diseases 0.000 title 1
- 201000005008 bacterial sepsis Diseases 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 260
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 260
- 238000000034 method Methods 0.000 claims abstract description 75
- 241000894007 species Species 0.000 claims abstract description 54
- 238000012217 deletion Methods 0.000 claims description 261
- 230000037430 deletion Effects 0.000 claims description 261
- 108091034117 Oligonucleotide Proteins 0.000 claims description 203
- 239000000523 sample Substances 0.000 claims description 195
- 230000005257 nucleotidylation Effects 0.000 claims description 188
- 125000003729 nucleotide group Chemical group 0.000 claims description 142
- 239000002773 nucleotide Substances 0.000 claims description 140
- 238000009396 hybridization Methods 0.000 claims description 127
- 108091093088 Amplicon Proteins 0.000 claims description 63
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 55
- 108090000623 proteins and genes Proteins 0.000 claims description 55
- 102000004169 proteins and genes Human genes 0.000 claims description 47
- 230000001717 pathogenic effect Effects 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 38
- 238000007792 addition Methods 0.000 claims description 35
- 108020004414 DNA Proteins 0.000 claims description 28
- 239000007787 solid Substances 0.000 claims description 25
- 244000052616 bacterial pathogen Species 0.000 claims description 20
- 241000194017 Streptococcus Species 0.000 claims description 17
- 206010040047 Sepsis Diseases 0.000 claims description 15
- 241000588923 Citrobacter Species 0.000 claims description 14
- 241000588914 Enterobacter Species 0.000 claims description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 244000005700 microbiome Species 0.000 claims description 11
- 241000588697 Enterobacter cloacae Species 0.000 claims description 9
- 208000037815 bloodstream infection Diseases 0.000 claims description 9
- 241000607734 Yersinia <bacteria> Species 0.000 claims description 8
- 241000191967 Staphylococcus aureus Species 0.000 claims description 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 6
- 241000588626 Acinetobacter baumannii Species 0.000 claims description 6
- 241000606124 Bacteroides fragilis Species 0.000 claims description 6
- 206010008631 Cholera Diseases 0.000 claims description 6
- 241000588917 Citrobacter koseri Species 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 6
- 241000588749 Klebsiella oxytoca Species 0.000 claims description 6
- 241000588747 Klebsiella pneumoniae Species 0.000 claims description 6
- 241000192087 Staphylococcus hominis Species 0.000 claims description 6
- 229940092534 citrobacter koseri Drugs 0.000 claims description 6
- 241001225321 Aspergillus fumigatus Species 0.000 claims description 5
- 241000589513 Burkholderia cepacia Species 0.000 claims description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 5
- 241000222173 Candida parapsilosis Species 0.000 claims description 5
- 241000222178 Candida tropicalis Species 0.000 claims description 5
- 241000606768 Haemophilus influenzae Species 0.000 claims description 5
- 241000606860 Pasteurella Species 0.000 claims description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 5
- 241000607715 Serratia marcescens Species 0.000 claims description 5
- 241000191984 Staphylococcus haemolyticus Species 0.000 claims description 5
- 241000194023 Streptococcus sanguinis Species 0.000 claims description 5
- 241000222126 [Candida] glabrata Species 0.000 claims description 5
- 229940091771 aspergillus fumigatus Drugs 0.000 claims description 5
- 208000032343 candida glabrata infection Diseases 0.000 claims description 5
- 229940055022 candida parapsilosis Drugs 0.000 claims description 5
- 229940047650 haemophilus influenzae Drugs 0.000 claims description 5
- 229940037649 staphylococcus haemolyticus Drugs 0.000 claims description 5
- 241000607528 Aeromonas hydrophila Species 0.000 claims description 4
- 241000228197 Aspergillus flavus Species 0.000 claims description 4
- 241000228245 Aspergillus niger Species 0.000 claims description 4
- 241001465318 Aspergillus terreus Species 0.000 claims description 4
- 241000193755 Bacillus cereus Species 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 241000222122 Candida albicans Species 0.000 claims description 4
- 241000186427 Cutibacterium acnes Species 0.000 claims description 4
- 241000194031 Enterococcus faecium Species 0.000 claims description 4
- 241000186779 Listeria monocytogenes Species 0.000 claims description 4
- 241000588772 Morganella morganii Species 0.000 claims description 4
- 241000588652 Neisseria gonorrhoeae Species 0.000 claims description 4
- 241000588650 Neisseria meningitidis Species 0.000 claims description 4
- 241000588770 Proteus mirabilis Species 0.000 claims description 4
- 241000607720 Serratia Species 0.000 claims description 4
- 241000607768 Shigella Species 0.000 claims description 4
- 241001464905 Staphylococcus saccharolyticus Species 0.000 claims description 4
- 241000122973 Stenotrophomonas maltophilia Species 0.000 claims description 4
- 241000194049 Streptococcus equinus Species 0.000 claims description 4
- 229940095731 candida albicans Drugs 0.000 claims description 4
- 229940076266 morganella morganii Drugs 0.000 claims description 4
- 229940055019 propionibacterium acne Drugs 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 241000589291 Acinetobacter Species 0.000 claims description 3
- 241000607516 Aeromonas caviae Species 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 3
- 241000190890 Capnocytophaga Species 0.000 claims description 3
- 241000186216 Corynebacterium Species 0.000 claims description 3
- 208000004232 Enteritis Diseases 0.000 claims description 3
- 241000589014 Kingella kingae Species 0.000 claims description 3
- 241000588653 Neisseria Species 0.000 claims description 3
- 241000606856 Pasteurella multocida Species 0.000 claims description 3
- 241000588768 Providencia Species 0.000 claims description 3
- 206010037660 Pyrexia Diseases 0.000 claims description 3
- 241001147691 Staphylococcus saprophyticus Species 0.000 claims description 3
- 241000192086 Staphylococcus warneri Species 0.000 claims description 3
- 241000607265 Vibrio vulnificus Species 0.000 claims description 3
- 208000025087 Yersinia pseudotuberculosis infectious disease Diseases 0.000 claims description 3
- 238000002405 diagnostic procedure Methods 0.000 claims description 3
- 229940051027 pasteurella multocida Drugs 0.000 claims description 3
- 241000193468 Clostridium perfringens Species 0.000 claims description 2
- 241001522882 Clostridium perfringens A Species 0.000 claims description 2
- 241000588748 Klebsiella Species 0.000 claims 3
- 241000224016 Plasmodium Species 0.000 claims 2
- 241000219095 Vitis Species 0.000 claims 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims 2
- 241000607534 Aeromonas Species 0.000 claims 1
- 241000194019 Streptococcus mutans Species 0.000 claims 1
- 238000003556 assay Methods 0.000 abstract description 26
- 230000002538 fungal effect Effects 0.000 abstract description 15
- 238000011895 specific detection Methods 0.000 abstract description 11
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 10
- 238000002493 microarray Methods 0.000 description 55
- 238000003752 polymerase chain reaction Methods 0.000 description 49
- 238000007403 mPCR Methods 0.000 description 31
- 238000006243 chemical reaction Methods 0.000 description 27
- 239000000047 product Substances 0.000 description 25
- 238000004458 analytical method Methods 0.000 description 23
- 239000000243 solution Substances 0.000 description 18
- 241000894006 Bacteria Species 0.000 description 17
- 241000233866 Fungi Species 0.000 description 16
- 230000000295 complement effect Effects 0.000 description 16
- 239000011541 reaction mixture Substances 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 244000053095 fungal pathogen Species 0.000 description 10
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 10
- 230000000813 microbial effect Effects 0.000 description 10
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 9
- 239000012634 fragment Substances 0.000 description 8
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 8
- 108060002716 Exonuclease Proteins 0.000 description 7
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 7
- 102000013165 exonuclease Human genes 0.000 description 7
- 239000002751 oligonucleotide probe Substances 0.000 description 7
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 6
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 6
- 239000011324 bead Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000011880 melting curve analysis Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 238000003753 real-time PCR Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 229930024421 Adenine Natural products 0.000 description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- 230000004544 DNA amplification Effects 0.000 description 4
- -1 Dynabeads (TM)) Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 241000588915 Klebsiella aerogenes Species 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 229940104302 cytosine Drugs 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 229940092559 enterobacter aerogenes Drugs 0.000 description 4
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 229940113082 thymine Drugs 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 229930010555 Inosine Natural products 0.000 description 3
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 3
- 238000010240 RT-PCR analysis Methods 0.000 description 3
- 241000191963 Staphylococcus epidermidis Species 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229960003786 inosine Drugs 0.000 description 3
- 239000000138 intercalating agent Substances 0.000 description 3
- 238000007837 multiplex assay Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108091023037 Aptamer Proteins 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000588919 Citrobacter freundii Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241001135265 Cronobacter sakazakii Species 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 238000007397 LAMP assay Methods 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- 238000002944 PCR assay Methods 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 241001138501 Salmonella enterica Species 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000193985 Streptococcus agalactiae Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 101150074253 TEF1 gene Proteins 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 244000052637 human pathogen Species 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000002887 multiple sequence alignment Methods 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000013615 primer Substances 0.000 description 2
- 239000002987 primer (paints) Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000011897 real-time detection Methods 0.000 description 2
- 101150079601 recA gene Proteins 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000011896 sensitive detection Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000005382 thermal cycling Methods 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- 101150099542 tuf gene Proteins 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- BUNGCZLFHHXKBX-UHFFFAOYSA-N 8-methoxypsoralen Natural products C1=CC(=O)OC2=C1C=C1CCOC1=C2OC BUNGCZLFHHXKBX-UHFFFAOYSA-N 0.000 description 1
- 229940027041 8-mop Drugs 0.000 description 1
- 241001135518 Acinetobacter lwoffii Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241001148106 Brucella melitensis Species 0.000 description 1
- 241001135194 Capnocytophaga canimorsus Species 0.000 description 1
- 241000580513 Citrobacter braakii Species 0.000 description 1
- 241001517041 Corynebacterium jeikeium Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000193814 Gemella haemolysans Species 0.000 description 1
- 241001147749 Gemella morbillorum Species 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 241000235645 Pichia kudriavzevii Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588777 Providencia rettgeri Species 0.000 description 1
- 241001092473 Quillaja Species 0.000 description 1
- 235000009001 Quillaja saponaria Nutrition 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 241000194008 Streptococcus anginosus Species 0.000 description 1
- 241000194042 Streptococcus dysgalactiae Species 0.000 description 1
- 241000194021 Streptococcus suis Species 0.000 description 1
- 241001468227 Streptomyces avermitilis Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 241000812633 Varicus Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 229940038698 brucella melitensis Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000013412 genome amplification Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002761 liquid phase assay Methods 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960004469 methoxsalen Drugs 0.000 description 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000002764 solid phase assay Methods 0.000 description 1
- 229940115920 streptococcus dysgalactiae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 101150010742 tuf2 gene Proteins 0.000 description 1
- 101150061352 tufA gene Proteins 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92974907P | 2007-07-11 | 2007-07-11 | |
| PCT/CA2008/001298 WO2009006743A1 (en) | 2007-07-11 | 2008-07-11 | Nucleic acid sequences and combination thereof for sensitive amplification and detection of bacterial and fungal sepsis pathogens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010532665A true JP2010532665A (ja) | 2010-10-14 |
| JP2010532665A5 JP2010532665A5 (enExample) | 2011-09-01 |
Family
ID=40228145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010515331A Pending JP2010532665A (ja) | 2007-07-11 | 2008-07-11 | 細菌性および真菌性敗血症の病原菌の高感度な増幅および検出用の核酸配列およびその組合せ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110151453A1 (enExample) |
| EP (1) | EP2176281A4 (enExample) |
| JP (1) | JP2010532665A (enExample) |
| AU (1) | AU2008274856A1 (enExample) |
| CA (1) | CA2693438A1 (enExample) |
| WO (1) | WO2009006743A1 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017175968A (ja) * | 2016-03-29 | 2017-10-05 | 東洋紡株式会社 | Ｐｃｒ反応溶液の検出感度を維持する方法 |
| TWI716083B (zh) * | 2018-12-28 | 2021-01-11 | 國立成功大學 | 敗血症的菌種預測系統與方法 |
| JP2022540716A (ja) * | 2019-07-19 | 2022-09-16 | セイフガード バイオシステムズ ホールディングズ リミテッド | プローブの組合せを用いたゲノム配列の検出、プローブ分子、および生物の特異的検出用のプローブを含むアレイ |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102031297B (zh) * | 2010-08-18 | 2013-01-30 | 李国辉 | 一种检测乳酒念珠菌的dna探针、基因芯片及其应用 |
| CN102230015B (zh) * | 2011-06-21 | 2013-05-01 | 北京出入境检验检疫局检验检疫技术中心 | 检测洋葱腐烂病菌的核苷酸序列和试剂盒 |
| RU2510856C2 (ru) * | 2012-02-24 | 2014-04-10 | Закрытое акционерное общество "Научно-производственная фирма ДНК-Технология" | НАБОР СИНТЕТИЧЕСКИХ ОЛИГОНУКЛЕОТИДОВ ДЛЯ ВЫЯВЛЕНИЯ ДНК ПАРОДОНТОПАТОГЕННОГО МИКРООРГАНИЗМА Candida albicans МЕТОДОМ ПОЛИМЕРАЗНОЙ ЦЕПНОЙ РЕАКЦИИ |
| EP3968023B1 (en) | 2013-08-19 | 2025-10-08 | Invitae Corporation | Assays for single molecule detection and use thereof |
| US10253376B2 (en) * | 2013-10-16 | 2019-04-09 | Wisconsin Alumni Research Foundation | DNA-based detection and identification of eight mastitis pathogens |
| US10260111B1 (en) * | 2014-01-20 | 2019-04-16 | Brett Eric Etchebarne | Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample |
| CN113528623A (zh) | 2015-02-18 | 2021-10-22 | 卓异生物公司 | 用于单分子检测的测定及其应用 |
| CN111073987B (zh) * | 2016-08-30 | 2022-09-20 | 上海市生物医药技术研究院 | 小肠结肠炎耶尔森氏菌的快速恒温检测方法、引物组及试剂盒 |
| CN106701994A (zh) * | 2017-02-20 | 2017-05-24 | 中国水产科学研究院淡水渔业研究中心 | 同步检测肺炎克雷伯氏菌和豚鼠气单胞菌的双重pcr引物及其检测方法 |
| EP4549590A3 (en) | 2017-08-24 | 2025-08-06 | Roche Diagnostics GmbH | Electrochemical detection of bacterial and/or fungal infections |
| US20190062809A1 (en) | 2017-08-24 | 2019-02-28 | Clinical Micro Sensors, Inc. (dba GenMark Diagnostics, Inc.) | Electrochemical detection of bacterial and/or fungal infections |
| JP2021502825A (ja) * | 2017-11-13 | 2021-02-04 | ライフ テクノロジーズ コーポレイション | 尿路微生物検出のための組成物、方法、およびキット |
| CN108913792A (zh) * | 2018-08-03 | 2018-11-30 | 暨南大学 | 基于数字pcr技术检测猪链球菌的引物和探针及其试剂盒与方法 |
| WO2020106158A1 (en) * | 2018-11-20 | 2020-05-28 | Acd Pharmaceuticals As | Serratia liquefaciens variant |
| FR3106834B1 (fr) * | 2020-01-30 | 2024-11-29 | Ocean Diagnostics | Nouveau procédé de PCR multiplexe et utilisation |
| CN112626263B (zh) * | 2021-01-20 | 2022-08-05 | 中国人民解放军总医院 | 酶切探针恒温检测呼吸道感染真菌病原体的试剂盒 |
| WO2022157672A1 (en) * | 2021-01-20 | 2022-07-28 | Safeguard Biosystems Holdings Ltd | Improved detection of genomic sequences and probe molecules therefor |
| TW202246525A (zh) * | 2021-01-20 | 2022-12-01 | 英商安全保護生技系統公司 | 基因體序列之改善之偵測及用於其之探針分子 |
| CN114182029A (zh) * | 2021-11-30 | 2022-03-15 | 石家庄君乐宝乳业有限公司 | 一种引物组合及其在检测乳制品中阪崎克罗诺杆菌的应用 |
| CN116516038B (zh) * | 2023-06-28 | 2023-09-15 | 圣湘生物科技股份有限公司 | 血流感染病原体联检并区分的组合物、试剂盒及用途 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003511015A (ja) * | 1999-09-28 | 2003-03-25 | インフェクティオ ダイアグノスティク（アイ．ディー．アイ．）インコーポレイティド | 高度に保存された遺伝子、および種特異的、属特異的、科特異的、群特異的および普遍的核酸プローブおよび増幅プライマーを発生させて、診断の臨床検体からの藻類、古細菌、細菌、真菌および寄生生物の微生物を急速に検出しかつ同定するためのそれらの使用 |
| WO2007012131A1 (en) * | 2005-07-27 | 2007-02-01 | Diagnostic Array Systems Pty Ltd | Method for the detection and/or identification of a microorganism |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2283458A1 (en) * | 1999-09-28 | 2001-03-28 | Michel G. Bergeron | Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify bacterial, fungal and parasitical pathogens from clinical specimens for diagnosis |
| US20070154903A1 (en) * | 2005-06-23 | 2007-07-05 | Nanosphere, Inc. | Selective isolation and concentration of nucleic acids from complex samples |
-
2008
- 2008-07-11 AU AU2008274856A patent/AU2008274856A1/en not_active Abandoned
- 2008-07-11 JP JP2010515331A patent/JP2010532665A/ja active Pending
- 2008-07-11 EP EP08783216A patent/EP2176281A4/en not_active Withdrawn
- 2008-07-11 US US12/668,622 patent/US20110151453A1/en not_active Abandoned
- 2008-07-11 WO PCT/CA2008/001298 patent/WO2009006743A1/en not_active Ceased
- 2008-07-11 CA CA2693438A patent/CA2693438A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003511015A (ja) * | 1999-09-28 | 2003-03-25 | インフェクティオ ダイアグノスティク（アイ．ディー．アイ．）インコーポレイティド | 高度に保存された遺伝子、および種特異的、属特異的、科特異的、群特異的および普遍的核酸プローブおよび増幅プライマーを発生させて、診断の臨床検体からの藻類、古細菌、細菌、真菌および寄生生物の微生物を急速に検出しかつ同定するためのそれらの使用 |
| WO2007012131A1 (en) * | 2005-07-27 | 2007-02-01 | Diagnostic Array Systems Pty Ltd | Method for the detection and/or identification of a microorganism |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017175968A (ja) * | 2016-03-29 | 2017-10-05 | 東洋紡株式会社 | Ｐｃｒ反応溶液の検出感度を維持する方法 |
| TWI716083B (zh) * | 2018-12-28 | 2021-01-11 | 國立成功大學 | 敗血症的菌種預測系統與方法 |
| JP2022540716A (ja) * | 2019-07-19 | 2022-09-16 | セイフガード バイオシステムズ ホールディングズ リミテッド | プローブの組合せを用いたゲノム配列の検出、プローブ分子、および生物の特異的検出用のプローブを含むアレイ |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009006743A1 (en) | 2009-01-15 |
| AU2008274856A1 (en) | 2009-01-15 |
| CA2693438A1 (en) | 2009-01-15 |
| US20110151453A1 (en) | 2011-06-23 |
| EP2176281A4 (en) | 2010-09-15 |
| EP2176281A1 (en) | 2010-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010532665A (ja) | 細菌性および真菌性敗血症の病原菌の高感度な増幅および検出用の核酸配列およびその組合せ | |
| US20100273159A1 (en) | Nested Multiplex Amplification Method for Identification of Multiple Biological Entities | |
| US12297511B2 (en) | Compositions and methods for detecting gastrointestinal pathogen nucleic acid | |
| Sławiak et al. | Multiplex detection and identification of bacterial pathogens causing potato blackleg and soft rot in Europe, using padlock probes | |
| US20130122505A1 (en) | Compositions and methods for detection of multiple microorganisms | |
| US9024002B2 (en) | Compositions and methods for detection of Salmonella species | |
| US9816145B2 (en) | Compositions for detection of Clostridium difficile | |
| US20140005061A1 (en) | Compositions and methods for detection of multiple microorganisms | |
| US9175354B2 (en) | Detection of Salmonella enterica subspecies enterica serovar Enteritidis in food and environmental samples, methods and compositions therefor | |
| WO2012003412A2 (en) | Inducible nucleic acid targets for detection of pathogens, methods and compositions thereof | |
| JP2017521083A (ja) | リステリア・モノサイトゲネス（Ｌｉｓｔｅｒｉａ ｍｏｎｏｃｙｔｏｇｅｎｅｓ）を検出するための配列およびこの配列の使用 | |
| JP2017213003A (ja) | サルモネラ属の検出のための配列およびその使用 | |
| JPWO2005118804A1 (ja) | Ａｌｉｃｙｃｌｏｂａｃｉｌｌｕｓ属細菌の特異的検出方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110711 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110711 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130723 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140121 |